MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Earnings & Estimates
USA - NASDAQ:MDGL - US5588681057 - Common Stock
443.01 USD
-6.63 (-1.47%)
443.01 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 180.133M | 890.01M 394.08% | 1.44B 61.80% | 2.138B 48.47% | 2.875B 34.47% | 3.858B 34.19% | 4.57B 18.46% | 5.076B 11.07% | 5.858B 15.41% | |||
| EBITDA YoY % growth | -293.13M -21.08% | -379.969M -29.62% | -496.779M -30.74% | -264.089M 46.84% | 61.492M 123.28% | 562.74M 815.14% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -293.6M -21.07% | -380.496M -29.60% | -497.875M -30.85% | -276.024M 44.56% | 82.148M 129.76% | 572.98M 597.50% | 1.246B 117.46% | 2.175B 74.56% | 2.855B 31.26% | 3.532B 23.71% | 4.248B 20.27% | |
| Operating Margin | N/A | N/A | -276.39% | -31.01% | 5.70% | 26.80% | 43.34% | 56.38% | 62.47% | 69.58% | 72.52% | |
| EPS YoY % growth | -17.23 -17.93% | -19.94 -15.73% | -22.11 -10.88% | -10.23 53.71% | 3.42 133.37% | 21.18 520.12% | 41.19 94.46% | 65.35 58.66% | 81.97 25.44% | 102.77 25.37% | 126.48 23.08% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.39 51.52% | -2.70 0.51% | -1.35 59.45% | 0.78 141.18% | 2.45 202.56% | 4.74 275.64% |
| Revenue Q2Q % growth | 248.86M 300.26% | 283.35M 174.25% | 302.22M 120.20% | 367.17M 72.54% | 368.54M 48.09% | 438.41M 54.72% |
| EBITDA Q2Q % growth | -32.997M 71.45% | -101.041M -53.32% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -55.598M 52.20% | -66.187M 1.21% | -5.894M 92.57% | 30M 163.56% | 82.905M 249.12% | 129.33M 295.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.90 73.24% | -3.71 | 1.81 | 48.79% |
| Q1 2025 Q2Q % growth | -3.32 55.01% | -3.84 | 0.52 | 13.46% |
| Q4 2024 Q2Q % growth | -2.71 52.29% | -4.33 | 1.62 | 37.40% |
| Q3 2024 Q2Q % growth | -4.92 7.87% | -7.05 | 2.13 | 30.22% |
| Q2 2024 Q2Q % growth | -7.10 -51.39% | -7.68 | 0.58 | 7.50% |
| Q1 2024 Q2Q % growth | -7.38 -74.47% | -6.41 | -0.97 | -15.12% |
| Q4 2023 Q2Q % growth | -5.68 -14.06% | -5.39 | -0.29 | -5.38% |
| Q3 2023 Q2Q % growth | -5.34 -12.42% | -5.02 | -0.32 | -6.30% |
| Q2 2023 Q2Q % growth | -4.69 -13.29% | -4.67 | -0.02 | -0.37% |
| Q1 2023 Q2Q % growth | -4.23 -25.89% | -5.04 | 0.81 | 16.00% |
| Q4 2022 Q2Q % growth | -4.98 -31.75% | -4.65 | -0.33 | -7.16% |
| Q3 2022 Q2Q % growth | -4.75 -25.33% | -4.24 | -0.51 | -12.11% |
| Q2 2022 Q2Q % growth | -4.14 -11.29% | -3.77 | -0.37 | -9.78% |
| Q1 2022 Q2Q % growth | -3.36 -1.20% | -3.69 | 0.33 | 9.02% |
| Q4 2021 Q2Q % growth | -3.78 1.05% | -3.95 | 0.17 | 4.41% |
| Q3 2021 Q2Q % growth | -3.79 -1.07% | -3.98 | 0.19 | 4.67% |
| Q2 2021 Q2Q % growth | -3.72 -16.98% | -3.66 | -0.06 | -1.75% |
| Q1 2021 Q2Q % growth | -3.32 -41.88% | -3.92 | 0.60 | 15.32% |
| Q4 2020 Q2Q % growth | -3.82 -112.22% | -3.93 | 0.11 | 2.85% |
| Q3 2020 Q2Q % growth | -3.75 -169.78% | -3.36 | -0.39 | -11.47% |
| Q2 2020 Q2Q % growth | -3.18 -148.44% | -2.50 | -0.68 | -27.07% |
| Q1 2020 Q2Q % growth | -2.34 -138.78% | -1.98 | -0.36 | -18.07% |
| Q4 2019 Q2Q % growth | -1.80 | -1.68 | -0.12 | -6.99% |
| Q3 2019 Q2Q % growth | -1.39 | -1.57 | 0.18 | 11.19% |
| Q2 2019 Q2Q % growth | -1.28 | -1.22 | -0.06 | -4.64% |
| Q1 2019 Q2Q % growth | -0.98 | -0.99 | 0.01 | 0.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 212.802M 1,353.76% | 165.56M | 47.242M | 28.53% |
| Q1 2025 Q2Q % growth | 137.25M | 116.1M | 21.15M | 18.22% |
| Q4 2024 Q2Q % growth | 103.32M | 100.53M | 2.79M | 2.78% |
| Q3 2024 Q2Q % growth | 62.175M | 34.873M | 27.302M | 78.29% |
| Q2 2024 Q2Q % growth | 14.638M | 3.981M | 10.657M | 267.70% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.89% | 35.03% | 4.05% | 24.41% |
| Revenue | -0.04% | 34.64% | -0.01% | 27.94% |